Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 21, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Faran to develop and commercialize firibastat in Greece.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Wednesday, April 29, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials has been announced by Quotient Sciences and CytoAgents.
read more
Rafael Pharmaceuticals has entered into an out-licensing agreement with Ono Pharmaceutical.
read more
Tuesday, December 17, 2019
Recipharm, the CDMO, has partnered with biotechnology company Aptahem, for the formulation of Apta-1 drug candidate.
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more
Friday, September 04, 2020
RedHill announced the selection of opaganib1 for severe COVID-19 pneumonia.
read more
Regeneron and Zai Lab announced a collaboration for the development and commercialization of REGN1979 in mainland China, Hong Kong, Taiwan and Macau.
read more
Relief and Acer announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.
read more
Thursday, December 14, 2017
reMYND and Novo Nordisk have entered into a license agreement to further develop reMYND's ReS39 therapeutic program of diabetes.
read more
Renaissance Acquisition Holdings, LLC (“Renaissance”), a portfolio company of RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has ...
read more
Tuesday, February 25, 2025
Rentschler Biopharma SE announced the promotion of Patrick Meyer, Ph.D., to Global Head of Business Development (BD), effective immediately.
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more
Ricerca Biosciences, an integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, announces Dr. G. Lynn Miesel as the new technical director.
read more
Richman Chemical Inc. (RCI), a custom synthesis, chemical manufacturing, and raw materials sourcing provider to the life science and chemical industries, announces a new partnership with Auditweaver, LLC., a specialty consultancy firm to the life ...
read more